Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829214 · ClinicalTrials.gov registry record · Phase 2
OTO-313 in Subjects With Unilateral Subjective Tinnitus
A Phase 2 study, sponsored by Otonomy.
- Completed
- Registry status
- Phase 2
- Development phase
- 153
- Enrollment target
NCT04829214 is a Phase 2 study that has completed, run by Otonomy. The registered enrollment target is 153 participants.
The verdict
NCT04829214, a Phase 2 study, has completed, sponsored by Otonomy.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of OTO-313 in subjects with unilateral tinnitus and to determine the safety and tolerability of OTO-313 in subjects with unilateral tinnitus.
Interventions
- DRUG Placebo
- DRUG OTO-313
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04829214
The ClinicalTrials.gov registry entry for NCT04829214 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otonomy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04829214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04829214 about?
NCT04829214 is a clinical study titled "OTO-313 in Subjects With Unilateral Subjective Tinnitus". The purpose of this study is to determine the efficacy of OTO-313 in subjects with unilateral tinnitus and to determine the safety and tolerability of OTO-313 in subjects with unilateral tinnitus.
What is the current status of trial NCT04829214?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 153 participants. The study started on 2021-03-22. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04829214?
The interventions under investigation include: Placebo (DRUG), OTO-313 (DRUG).
Who is sponsoring clinical trial NCT04829214?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.